Header Logo

Connection

JAMES HERLIHY to Fetal Blood

Back to Details
This is a "connection" page, showing publications JAMES HERLIHY has written about Fetal Blood.
JAMES HERLIHY
Connection Strength
0.046
Fetal Blood
  1. Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS. Blood Adv. 2023 07 11; 7(13):3075-3079.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.